Priser
Platform
Blog
Om os
Download
002099
Zhejiang Hisoar Pharmaceutical Co
Shenzhen Stock Exchange (Hong Kong)
0

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I ZHEJIANG HISOAR PHARMACEUTICAL CO MED ENDAVU: Køb Zhejiang Hisoar Pharmaceutical Co ($002099) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Zhejiang Hisoar Pharmaceutical Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Om

Zhejiang Hisun Pharmaceutical Co., Ltd. is a leading player in the pharmaceutical industry, primarily focusing on the research, development, manufacture, and sale of pharmaceutical products globally. Established in China, Hisun Pharmaceutical is renowned for its extensive portfolio, which includes antibiotics, antineoplastic drugs, cardiovascular agents, and animal health products. The company plays a crucial role in the healthcare sector, leveraging advanced biotechnology and chemical synthesis to enhance drug formulations and meet global health standards. Hisun Pharmaceutical serves various markets by distributing its products to healthcare providers, hospitals, and pharmacies around the world. It has strategic partnerships and collaborations with other pharmaceutical giants, enabling it to expand its market reach and foster innovation. As a publicly traded entity, Zhejiang Hisun Pharmaceutical is integral to the health and pharmaceutical sectors, frequently contributing to both preventive and curative healthcare solutions. The company's commitment to quality and innovation has solidified its status as a key contributor to pharmaceutical advancements.

Information

Ticker002099
Land
Kina
Antal medarbejdere2.736
Hjemmesidehisoar.com
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk

Udbytter

0,1CNH
'18
0,3CNH
'19
0,3CNH
'20
0,02CNH
'21
0,1CNH
'22
0,05CNH
'23
Ex-udbytte-dato24. maj 2023
Udbytteafkast0,97%